PTC Therapeutics, Inc.
US ˙ NasdaqGS ˙ US69366J2006

SecurityPTCT / PTC Therapeutics, Inc.
InstitutionWalleye Capital LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Walleye Capital LLC ownership in PTCT / PTC Therapeutics, Inc.

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 0 shares of PTC Therapeutics, Inc. (US:PTCT) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 18,074 shares of PTC Therapeutics, Inc.. The current value of the position is $0 USD.

Walleye Capital LLC has a history of taking positions in derivatives of the underlying security (PTCT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

PTCT / PTC Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 PTC THERAPEUTICS COM 69366J200 0 -100.00 0
2026-05-08 2026-03-31 13F PTC THERAPEUTICS COM 69366J200 0 -100.00 0
2026-02-13 2025-12-31 13F PTC THERAPEUTICS COM 69366J200 18,074 6,731 59.34 1,373 97.13 0.0042
2025-11-14 2025-09-30 13F PTC THERAPEUTICS COM 69366J200 11,343 -26,564 -70.08 696 -62.40 0.0026
2025-08-13 2025-06-30 13F PTC THERAPEUTICS COM 69366J200 37,907 -31,253 -45.19 1,851 -47.47 0.0072
2025-05-14 2025-03-31 13F PTC THERAPEUTICS COM 69366J200 69,160 -40,844 -37.13 3,524 -29.02 0.0159
2025-02-13 2024-12-31 13F PTC THERAPEUTICS COM 69366J200 110,004 110,004 4,966 0.0121
2024-11-14 2024-09-30 13F PTC THERAPEUTICS COM 69366J200 0 -85,147 -100.00 0 -100.00
2024-08-14 2024-06-30 13F PTC THERAPEUTICS COM 69366J200 85,147 73,484 630.06 2,604 667.85 0.0046
2024-05-15 2024-03-31 13F PTC THERAPEUTICS COM 69366J200 11,663 11,663 339 0.0006
2024-02-14 2023-12-31 13F PTC THERAPEUTICS COM 69366J200 0 -72,030 -100.00 0 -100.00
2023-11-21 2023-09-30 13F/A-1 PTC THERAPEUTICS COM 69366J200 72,030 65,226 958.64 1,614 484.78 0.0041
2023-11-14 2023-09-30 13F PTC THERAPEUTICS COM 69366J200 72,030 65,226 1,614 0.0042
2023-08-14 2023-06-30 13F PTC THERAPEUTICS COM 69366J200 6,804 -76,942 -91.88 277 -93.20 0.0010
2023-05-15 2023-03-31 13F PTC THERAPEUTICS COM 69366J200 83,746 -11,485 -12.06 4,057 11.61 0.0608
2023-02-14 2022-12-31 13F PTC THERAPEUTICS COM 69366J200 95,231 95,231 3,635 0.0663
2022-11-14 2022-09-30 13F PTC THERAPEUTICS COM 69366J200 0 -60,412 -100.00 0 -100.00
2022-08-19 2022-06-30 13F/A-1 PTC THERAPEUTICS COM 69366J200 60,412 50,379 502.13 2,420 547.06 0.0667
2022-08-08 2022-06-30 13F PTC THERAPEUTICS COM 69366J200 60,412 50,379 2,420 0.0667
2022-05-27 2022-03-31 13F/A-01 PTC THERAPEUTICS COM 69366J200 10,033 10,033 374 0.0100
2022-05-16 2022-03-31 13F PTC THERAPEUTICS COM 69366J200 10,033 10,033 374 0.0076
2020-05-15 2020-03-31 13F PTC THERAPEUTICS COM 69366J200 0 -1,500 -100.00 0 -100.00
2020-02-14 2019-12-31 13F PTC THERAPEUTICS COM 69366J200 1,500 1,500 72 0.0047
2019-11-14 2019-09-30 13F PTC THERAPEUTICS COM 69366J200 0 -1,294 -100.00 0 -100.00
2019-08-14 2019-06-30 13F PTC THERAPEUTICS COM 69366J200 1,294 1,294 58 0.0064
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A PTC THERAPEUTICS COM Call 0 -100.00 0 n/a n/a n/a
2026-05-08 2026-03-31 13F PTC THERAPEUTICS COM Call 0 -100.00 0 n/a n/a n/a
2026-02-13 2025-12-31 13F PTC THERAPEUTICS COM Call 800 61 n/a n/a n/a
2024-08-14 2024-06-30 13F PTC THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F PTC THERAPEUTICS COM Call 600 17 n/a n/a n/a
2023-08-14 2023-06-30 13F PTC THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-15 2023-03-31 13F PTC THERAPEUTICS COM Call 1,400 250.00 68 346.67 n/a n/a n/a
2023-02-14 2022-12-31 13F PTC THERAPEUTICS COM Call 400 15 n/a n/a n/a
2020-05-15 2020-03-31 13F PTC THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F PTC THERAPEUTICS COM Call 34,800 -17.92 1,671 16.53 n/a n/a n/a
2019-11-14 2019-09-30 13F PTC THERAPEUTICS COM Call 42,400 863.64 1,434 624.24 n/a n/a n/a
2019-08-14 2019-06-30 13F PTC THERAPEUTICS COM Call 4,400 -31.25 198 -17.84 n/a n/a n/a
2019-08-14 2019-03-31 13F/A PTC THERAPEUTICS COM Call 6,400 241 n/a n/a n/a
2019-05-15 2019-03-31 13F PTC THERAPEUTICS COM Call 6,400 241 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A PTC THERAPEUTICS COM Put 0 -100.00 0 n/a n/a n/a
2026-05-08 2026-03-31 13F PTC THERAPEUTICS COM Put 0 -100.00 0 n/a n/a n/a
2026-02-13 2025-12-31 13F PTC THERAPEUTICS COM Put 5,900 210.53 448 286.21 n/a n/a n/a
2025-11-14 2025-09-30 13F PTC THERAPEUTICS COM Put 1,900 280.00 117 383.33 n/a n/a n/a
2025-08-13 2025-06-30 13F PTC THERAPEUTICS COM Put 500 24 n/a n/a n/a
2024-08-14 2024-06-30 13F PTC THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F PTC THERAPEUTICS COM Put 1,500 44 n/a n/a n/a
2023-08-14 2023-06-30 13F PTC THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-15 2023-03-31 13F PTC THERAPEUTICS COM Put 5,900 286 n/a n/a n/a
2020-05-15 2020-03-31 13F PTC THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F PTC THERAPEUTICS COM Put 3,300 312.50 158 485.19 n/a n/a n/a
2019-11-14 2019-09-30 13F PTC THERAPEUTICS COM Put 800 -77.14 27 -82.91 n/a n/a n/a
2019-08-14 2019-06-30 13F PTC THERAPEUTICS COM Put 3,500 158 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.